Background illustration for clinical trials search

Paid Clinical Trials Baltimore

Discover 2,405 paid clinical trials in Baltimore, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

for
Intracranial Meningioma, Recurrent Meningioma,
Location: Baltimore MD, Fairfax VA, Hershey PA, Philadelphia PA,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT02523014

Phase 2, Recruiting

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

for
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia,
Location: Baltimore MD, Washington D.C. DC, Falls Church VA,
Sponsor: PedAL BCU, LLC

Sex: All

Age: 0 - 22

Code: NCT04726241

Phase 1, Phase 2, Recruiting

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

for
Central Nervous System Nongerminomatous Germ Cell Tumor,
Location: Baltimore MD, Washington D.C. DC, Wilmington DE,
Sponsor: Children's Oncology Group

Sex: All

Age: 3 - 29

Code: NCT04684368

Phase 2, Recruiting

Combination Radiotherapy and Radiopharmaceutical Therapy Treatment Planning for Thyroid Cancer

for
Recurrent Thyroid Cancer
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 18 - 70+

Code: NCT04892303

Phase 1, Recruiting

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

for
Advanced Non-Small Cell Lung Cancer,
Location: Baltimore MD, Fairfax VA, Richmond VA,
Sponsor: Mirati Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT04613596

Phase 2, Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

for
Renal Pelvis and Ureter Urothelial Carcinoma
Location: Baltimore MD, Washington D.C. DC, Hershey PA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04628767

Phase 2, Phase 3, Recruiting

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

for
Solid Tumors, Hematologic Malignancies
Location: Baltimore MD, Columbia MD, Philadelphia PA, Richmond VA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT03486873

Phase 3, Recruiting

KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer

for
Colorectal Cancer, Pancreatic Cancer
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 18+

Code: NCT06411691

Phase 1, Recruiting

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

for
Acute Leukemia of Ambiguous Lineage,
Location: Baltimore MD, Washington D.C. DC, Wilmington DE,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 1

Code: NCT06317662

Phase 2, Recruiting

Study in Patients With Breast Cancer Leptomeningeal Metastasis

for
Leptomeningeal Metastasis of Breast Cancer
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 0+

Code: NCT06638294

Recruiting

Improving Office Based Treatment of Opioid Use Disorder With Technology

for
Opioid-use Disorder
Location: Baltimore MD
Sponsor: MedicaSafe, Inc.

Sex: All

Age: 18 - 65

Code: NCT03586466

Recruiting

NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection

for
Coronavirus Infection, Severe Acute Respiratory Infection,
Location: Baltimore MD, Bethesda MD, Washington DC,
Sponsor: Biomed Industries, Inc.

Sex: All

Age: 18 - 70+

Code: NCT04452565

Phase 2, Phase 3, Recruiting

Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN

for
Lupus Nephritis
Location: Baltimore MD, Columbus OH, Charlotte NC, Hixson TN
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06527872

Recruiting

Study of SIR2501 in Solid Tumor Patients Receiving Paclitaxel

for
Chemotherapy-induced Peripheral Neuropathy
Location: Baltimore MD, East Brunswick NJ, Hollywood FL
Sponsor: Sironax USA, Inc.

Sex: All

Age: 18+

Code: NCT07765446

Phase 2, Recruiting

Transition to KPL-387 Monotherapy Dosing & Administration Study

for
Recurrent Pericarditis, Heart Diseases, Pericarditis
Location: Baltimore MD, Richmond VA, Charlottesville VA,
Sponsor: Kiniksa Pharmaceuticals International, plc

Sex: All

Age: 18 - 70+

Code: NCT07288216

Phase 2, Recruiting

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

for
Gastrointestinal Neoplasms
Location: Baltimore MD, Fairfax VA, Washington D.C. DC,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07218926

Phase 3, Recruiting

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection

for
Hepatitis B Virus Infection
Location: Baltimore MD, Richmond VA, Peachtree Corners GA,
Sponsor: GigaGen, Inc.

Sex: All

Age: 18+

Code: NCT07024641

Phase 1, Recruiting

Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387

for
Pericarditis, Pericarditis Acute, Recurrent Pericarditis
Location: Baltimore MD, Washington D.C. DC, Richmond VA,
Sponsor: Kiniksa Pharmaceuticals International, plc

Sex: All

Age: 18 - 70+

Code: NCT07010159

Phase 2, Phase 3, Recruiting

A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia

for
Congenital Adrenal Hyperplasia,
Location: Baltimore MD, Philadelphia PA, Pittsburgh PA,
Sponsor: Crinetics Pharmaceuticals Inc.

Sex: All

Age: 18 - 70+

Code: NCT07144163

Phase 3, Recruiting

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Rosedale MD, Baltimore MD, Potomac MD, Wilmington DE,
Sponsor: AstraZeneca

Sex: All

Age: 40 - 70+

Code: NCT06878261

Phase 3, Recruiting